🍽️ high-saturated fat diet

AI Engines For more Details: PerplexityKagi LabsYou

  1. Cardiovascular Health: High intake of saturated fats has long been associated with an increased risk of cardiovascular diseases (CVD), including coronary artery disease, heart attacks, and strokes. Saturated fats can raise levels of LDL cholesterol ("bad" cholesterol), which is a risk factor for CVD. Therefore, a diet high in saturated fats may exacerbate existing cardiovascular conditions and contribute to the development of new ones.

  2. Obesity and Weight Gain: Saturated fats are energy-dense and can contribute to excess calorie intake, potentially leading to weight gain and obesity if not balanced with energy expenditure. Obesity is a risk factor for numerous health conditions, including type 2 diabetes, hypertension, and certain cancers.

  3. Insulin Resistance and Type 2 Diabetes: High intake of saturated fats has been linked to insulin resistance, a condition in which cells become less responsive to insulin, leading to elevated blood sugar levels. This can contribute to the development of type 2 diabetes and its associated complications.

  4. Inflammation: Some studies suggest that diets high in saturated fats may promote inflammation in the body, which is associated with various chronic diseases, including cardiovascular disease, diabetes, and certain cancers.

  5. Liver Health: Excessive consumption of saturated fats may contribute to non-alcoholic fatty liver disease (NAFLD), a condition characterized by the accumulation of fat in the liver. NAFLD can progress to more severe liver conditions, such as non-alcoholic steatohepatitis (NASH) and liver fibrosis.

  6. Cognitive Function: Some research suggests that diets high in saturated fats may impair cognitive function and increase the risk of neurodegenerative diseases, such as Alzheimer's disease. However, more research is needed to fully understand the relationship between dietary fat intake and cognitive health.

  7. Hormonal Imbalance: Saturated fats may influence hormone levels and signaling pathways in the body, which could have implications for reproductive health and hormone-related conditions such as polycystic ovary syndrome (PCOS).

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of high-saturated fat diet On Probiotics

Rank Probiotic Impact
order Micrococcales Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium bifidum Reduces
species Bifidobacterium breve Reduces
species Bifidobacterium catenulatum Reduces
species Bifidobacterium longum Reduces
species Bifidobacterium pseudocatenulatum Reduces

Bacteria Impacted by high-saturated fat diet

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Actinomycetes class Decreases 📓 Source Study
Acidimicrobiia class Decreases 👶 Source Study
Actinomycetes class Decreases 👶 Source Study
Coriobacteriia class Decreases 👶 Source Study
Nitriliruptoria class Decreases 👶 Source Study
Rubrobacteria class Decreases 👶 Source Study
Thermoleophilia class Decreases 👶 Source Study
Bifidobacteriaceae family Decreases 📓 Source Study
Coriobacteriaceae family Decreases 📓 Source Study Associated with Iron Deficiency (Low)
Desulfovibrionaceae family Decreases 📓 Source Study
Adlercreutzia genus Decreases 📓 Source Study
Bifidobacterium genus Decreases 📓 Source Study
Bilophila genus Decreases 📓 Source Study High Level Cause Brain Fog(Cognitive impairment)
Aeriscardovia genus Decreases 👶 Source Study
Alloscardovia genus Decreases 👶 Source Study
Bifidobacterium genus Decreases 👶 Source Study
Bilophila genus Decreases 👶 Source Study High Level Cause Brain Fog(Cognitive impairment)
Bombiscardovia genus Decreases 👶 Source Study
Collinsella genus Decreases 👶 Source Study proinflammatory
Coriobacterium genus Decreases 👶 Source Study
Cupidesulfovibrio genus Decreases 👶 Source Study
Desulfobaculum genus Decreases 👶 Source Study
Desulfocurvibacter genus Decreases 👶 Source Study
Desulfocurvus genus Decreases 👶 Source Study
Desulfohalovibrio genus Decreases 👶 Source Study
Desulfolutivibrio genus Decreases 👶 Source Study
Desulfovibrio genus Decreases 👶 Source Study
Enorma genus Decreases 👶 Source Study
Fundidesulfovibrio genus Decreases 👶 Source Study
Galliscardovia genus Decreases 👶 Source Study
Gardnerella genus Decreases 👶 Source Study
Halodesulfovibrio genus Decreases 👶 Source Study
Humidesulfovibrio genus Decreases 👶 Source Study
Lawsonia genus Decreases 👶 Source Study
Mailhella genus Decreases 👶 Source Study
Maridesulfovibrio genus Decreases 👶 Source Study
Megalodesulfovibrio genus Decreases 👶 Source Study
Neoscardovia genus Decreases 👶 Source Study
Oceanidesulfovibrio genus Decreases 👶 Source Study
Olegusella genus Decreases 👶 Source Study
Oleidesulfovibrio genus Decreases 👶 Source Study
Paradesulfovibrio (ex Waite et al. 2020) genus Decreases 👶 Source Study
Parascardovia genus Decreases 👶 Source Study
Parvibacter genus Decreases 👶 Source Study
Paucidesulfovibrio genus Decreases 👶 Source Study
Pseudodesulfovibrio genus Decreases 👶 Source Study
Pseudoscardovia genus Decreases 👶 Source Study
Salidesulfovibrio genus Decreases 👶 Source Study
Scardovia genus Decreases 👶 Source Study
Senegalimassilia genus Decreases 👶 Source Study
Solidesulfovibrio genus Decreases 👶 Source Study
Actinomycetes incertae sedis no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
unclassified Actinomycetes no rank Decreases 👶 Source Study
unclassified Actinomycetota no rank Decreases 👶 Source Study
unclassified Adlercreutzia no rank Decreases 👶 Source Study
unclassified Bifidobacterium no rank Decreases 👶 Source Study
unclassified Bilophila no rank Decreases 👶 Source Study
unclassified Coriobacteriaceae no rank Decreases 👶 Source Study
Acidothermales order Decreases 👶 Source Study
Actinomycetales order Decreases 👶 Source Study
Actinopolysporales order Decreases 👶 Source Study
Bifidobacteriales order Decreases 👶 Source Study
Candidatus Nanopelagicales order Decreases 👶 Source Study
Catenulisporales order Decreases 👶 Source Study
Cryptosporangiales order Decreases 👶 Source Study
Frankiales order Decreases 👶 Source Study
Geodermatophilales order Decreases 👶 Source Study
Glycomycetales order Decreases 👶 Source Study
Jatrophihabitantales order Decreases 👶 Source Study
Jiangellales order Decreases 👶 Source Study
Kineosporiales order Decreases 👶 Source Study
Kitasatosporales order Decreases 👶 Source Study
Micrococcales order Decreases 👶 Source Study
Micromonosporales order Decreases 👶 Source Study
Motilibacterales order Decreases 👶 Source Study
Mycobacteriales order Decreases 👶 Source Study
Nakamurellales order Decreases 👶 Source Study
Propionibacteriales order Decreases 👶 Source Study
Pseudonocardiales order Decreases 👶 Source Study
Sporichthyales order Decreases 👶 Source Study
Streptosporangiales order Decreases 👶 Source Study
Eggerthellales order Decreases ⚗️ Source Study
Actinomycetota phylum Decreases 📓 Source Study
Bifidobacterium sp. species Decreases 👶 Source Study
Bifidobacterium sp. 113 species Decreases 👶 Source Study
Bifidobacterium sp. 120 species Decreases 👶 Source Study
Bifidobacterium sp. 138 species Decreases 👶 Source Study
Bifidobacterium sp. 65947 species Decreases 👶 Source Study
Bifidobacterium sp. h12 species Decreases 👶 Source Study
Bifidobacterium sp. JCM 6439 species Decreases 👶 Source Study
Bifidobacterium sp. M45 species Decreases 👶 Source Study
Bifidobacterium sp. MC_8 species Decreases 👶 Source Study
Bifidobacterium sp. MSTE12 species Decreases 👶 Source Study
Bifidobacterium sp. MSX5B species Decreases 👶 Source Study
Bifidobacterium sp. PL1 species Decreases 👶 Source Study
Bilophila sp. 4_1_30 species Decreases 👶 Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Adlercreutzia caecimuris species Decreases 👶 Source Study
Adlercreutzia equolifaciens species Decreases 👶 Source Study
Adlercreutzia hattorii species Decreases 👶 Source Study
Adlercreutzia mucosicola species Decreases 👶 Source Study
Adlercreutzia muris species Decreases 👶 Source Study
Adlercreutzia sp. species Decreases 👶 Source Study
Bifidobacterium actinocoloniiforme species Decreases 👶 Source Study
Bifidobacterium adolescentis species Decreases 👶 Source Study
Bifidobacterium aesculapii species Decreases 👶 Source Study
Bifidobacterium angulatum species Decreases 👶 Source Study
Bifidobacterium animalis species Decreases 👶 Source Study
Bifidobacterium asteroides species Decreases 👶 Source Study
Bifidobacterium avesanii species Decreases 👶 Source Study
Bifidobacterium biavatii species Decreases 👶 Source Study
Bifidobacterium bifidum species Decreases 👶 Source Study
Bifidobacterium bohemicum species Decreases 👶 Source Study
Bifidobacterium bombi species Decreases 👶 Source Study
Bifidobacterium boum species Decreases 👶 Source Study
Bifidobacterium breve species Decreases 👶 Source Study
Bifidobacterium callitrichidarum species Decreases 👶 Source Study
Bifidobacterium callitrichos species Decreases 👶 Source Study
Bifidobacterium catenulatum species Decreases 👶 Source Study
Bifidobacterium choerinum species Decreases 👶 Source Study
Bifidobacterium commune species Decreases 👶 Source Study
Bifidobacterium coryneforme species Decreases 👶 Source Study
Bifidobacterium cuniculi species Decreases 👶 Source Study
Bifidobacterium dentium species Decreases 👶 Source Study
Bifidobacterium eulemuris species Decreases 👶 Source Study
Bifidobacterium faecale species Decreases 👶 Source Study
Bifidobacterium gallicum species Decreases 👶 Source Study
Bifidobacterium imperatoris species Decreases 👶 Source Study
Bifidobacterium indicum species Decreases 👶 Source Study
Bifidobacterium lemurum species Decreases 👶 Source Study
Bifidobacterium longum species Decreases 👶 Source Study
Bifidobacterium magnum species Decreases 👶 Source Study
Bifidobacterium merycicum species Decreases 👶 Source Study
Bifidobacterium minimum species Decreases 👶 Source Study
Bifidobacterium mongoliense species Decreases 👶 Source Study
Bifidobacterium moukalabense species Decreases 👶 Source Study
Bifidobacterium myosotis species Decreases 👶 Source Study
Bifidobacterium porcinum species Decreases 👶 Source Study
Bifidobacterium pseudocatenulatum species Decreases 👶 Source Study
Bifidobacterium pseudolongum species Decreases 👶 Source Study
Bifidobacterium psychraerophilum species Decreases 👶 Source Study
Bifidobacterium pullorum species Decreases 👶 Source Study
Bifidobacterium reuteri species Decreases 👶 Source Study
Bifidobacterium ruminantium species Decreases 👶 Source Study
Bifidobacterium saguini species Decreases 👶 Source Study
Bifidobacterium scardovii species Decreases 👶 Source Study
Bifidobacterium simiae species Decreases 👶 Source Study
Bifidobacterium sp. group II-3 species Decreases 👶 Source Study
Bifidobacterium sp. N5G01 species Decreases 👶 Source Study
Bifidobacterium stellenboschense species Decreases 👶 Source Study
Bifidobacterium stercoris species Decreases 👶 Source Study
Bifidobacterium subtile species Decreases 👶 Source Study
Bifidobacterium thermacidophilum species Decreases 👶 Source Study
Bifidobacterium thermophilum species Decreases 👶 Source Study
Bifidobacterium tissieri species Decreases 👶 Source Study
Bifidobacterium tsurumiense species Decreases 👶 Source Study
Bilophila sp. species Decreases 👶 Source Study
Bilophila wadsworthia species Decreases 👶 Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Actinobacteridae subclass Decreases 👶 Source Study
Candidatus Actinomarinidae subclass Decreases 👶 Source Study
Bifidobacterium pullorum subsp. gallinarum subspecies Decreases 👶 Source Study
Bifidobacterium pullorum subsp. saeculare subspecies Decreases 👶 Source Study

Impact of high-saturated fat diet on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.3 0.3
Acne 0.8 -0.8
ADHD 2.3 2.3
Allergic Rhinitis (Hay Fever) 1.7 -1.7
Allergies 1.8 0.7 1.57
Allergy to milk products 0.8 -0.8
Alopecia (Hair Loss) 0.2 0.2
Alzheimer's disease 2.7 2 0.35
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.3 0.3
Ankylosing spondylitis 1.5 1.5
Anorexia Nervosa 0.5 0.5
Antiphospholipid syndrome (APS) 0.3 -0.3
Asthma 0.3 0.5 -0.67
Atherosclerosis 1 1
Atrial fibrillation 0.7 0.7 0
Autism 1.2 2 -0.67
Barrett esophagus cancer 0.5 0.5
Bipolar Disorder 1.2 1.2
Brain Trauma 1.2 1.2
Carcinoma 1.3 1 0.3
Celiac Disease 0.8 1.3 -0.63
Cerebral Palsy 0.3 0.3
Chronic Fatigue Syndrome 0.3 0.3 0
Chronic Kidney Disease 0.2 0.2 0
Chronic Urticaria (Hives) 0.8 0.8
Colorectal Cancer 0.3 0.5 -0.67
Constipation 0.2 -0.2
Coronary artery disease 0.2 0.2
COVID-19 2 2.2 -0.1
Crohn's Disease 2 1.2 0.67
cystic fibrosis 0.5 0.3 0.67
Depression 2.4 1.7 0.41
Dermatomyositis 0.3 -0.3
Eczema 0.8 -0.8
Endometriosis 1.5 0.2 6.5
Epilepsy 1 0.8 0.25
erectile dysfunction 0.2 0.2
Fibromyalgia 0.3 -0.3
Functional constipation / chronic idiopathic constipation 0.5 0.5 0
gallstone disease (gsd) 0.3 -0.3
Generalized anxiety disorder 0.5 -0.5
giant cell arteritis 0.2 -0.2
Graves' disease 2 0.3 5.67
Hashimoto's thyroiditis 0.3 0.7 -1.33
Hidradenitis Suppurativa 0.3 0.3
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.5 0.5 0
hypercholesterolemia (High Cholesterol) 0.5 0.5
hyperglycemia 0.5 0.5 0
Hyperlipidemia (High Blood Fats) 1 0.2 4
hypersomnia 0.5 -0.5
hypertension (High Blood Pressure 1.7 1 0.7
Hypothyroidism 0.8 -0.8
IgA nephropathy (IgAN) 0.3 -0.3
Inflammatory Bowel Disease 1 0.7 0.43
Insomnia 0.8 0.8
Intelligence 0.5 -0.5
Intracranial aneurysms 0.2 -0.2
Irritable Bowel Syndrome 1.5 0.8 0.88
Juvenile idiopathic arthritis 0.5 0.5
Liver Cirrhosis 1.3 0.7 0.86
Long COVID 3.8 3.3 0.15
ME/CFS with IBS 0.3 -0.3
ME/CFS without IBS 0.3 -0.3
Menopause 0.3 0.2 0.5
Metabolic Syndrome 3.5 2.2 0.59
Mood Disorders 3.4 2.8 0.21
Multiple Sclerosis 2.5 0.5 4
Multiple system atrophy (MSA) 0.5 -0.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.7 1.2 -0.71
NonCeliac Gluten Sensitivity 0.3 -0.3
Obesity 3.3 0.8 3.12
obsessive-compulsive disorder 0.5 -0.5
Osteoarthritis 0.2 -0.2
pancreatic cancer 0.2 -0.2
Parkinson's Disease 2.2 1 1.2
Polycystic ovary syndrome 0.3 -0.3
Postural orthostatic tachycardia syndrome 0.3 -0.3
Premenstrual dysphoric disorder 0.5 0.5
primary biliary cholangitis 0.2 0.2 0
Psoriasis 1.2 1.2
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2.8 0.5 4.6
Rosacea 1.2 1.2
Schizophrenia 2.3 2.3 0
scoliosis 0.3 -0.3
Sjögren syndrome 0.2 1.3 -5.5
Sleep Apnea 0.7 0.8 -0.14
Small Intestinal Bacterial Overgrowth (SIBO) 0.2 0.2 0
Stress / posttraumatic stress disorder 0.8 2 -1.5
Systemic Lupus Erythematosus 0.3 1.3 -3.33
Tic Disorder 0.5 -0.5
Type 1 Diabetes 0.8 0.3 1.67
Type 2 Diabetes 3.5 0.7 4
Ulcerative colitis 1.8 1.8 0
Unhealthy Ageing 0.5 0.8 -0.6

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.